The US Department of Justice has challenged plans to dissolve Purdue Pharma, a maker of oxycontin drugs that has been blamed for the country’s opioid crisis, while protecting its founders from proceedings.
Under the contract, the Sacklers who set up the company and profited would have to pay $ 4.5 billion, but they couldn’t be taken to court again for the drug.
In a court filing released Wednesday, Judiciary Commissioner William Harrington is accountable for the national addiction crisis that has caused more than 500,000 overdose deaths in the United States over the past two decades. Claims to be inadequate to provide.
The agreement “harms both the general public and countless individuals by extinguishing the rights that opioid victims probably hold over thousands of members of the Sackler family and related parties.”
The government argues that if the settlement is allowed to proceed, there will be no “complete accounting” for the roles of these individuals and groups in the “opioid disaster.”
Attorney Generals in Washington, Maryland, Oregon, and Connecticut also oppose the deal, but other states support it.
Purdue pleaded guilty to three people last year in the face of an avalanche of proceedings Criminal liability Beyond the aggressive effort to promote the sale of oxycontin, a highly addictive prescription analgesic.
Under the terms of the agreement, the company will be sold by 2024 and replaced by a new entity managed by the trust, limiting its involvement in the sale of opioid products.
Purdue also needs to create a repository of tens of millions of documents detailing its sales and marketing practices.
Slanders, including Washington State Attorney General Bob Ferguson, claim they can “off-hook” their families, but Sucklers welcomed the deal and avoided a proceeding that could take years to resolve. He said.
Like many American millionaires, Sackler donated to leading institutions such as the Metropolitan Museum of Art in New York. Many institutions currently ban donations.
According to Forbes, family wealth declined during the crisis, but it was still estimated at about $ 10.8 billion at the end of last year, with much of its wealth coming from Purdue University.
© 2021 AFP
Quote: For the United States, Purdue Pharma opioid settlement acquired on September 16, 2021 from https: //medicalxpress.com/news/2021-09-block-purdue-pharma-opioid-settlement.html (September 16, 2021) Moves to block the day)
This document is subject to copyright. No part may be reproduced without written permission, except for fair transactions for personal investigation or research purposes. The content is provided for informational purposes only.
US moves to block Purdue Pharma opioid settlement Source link US moves to block Purdue Pharma opioid settlement